Containing costs in chronic disease: monitoring strategies in the gold therapy of rheumatoid arthritis.
D000380:Agranulocytosis / Q000139:chemically induced / Q000175:diagnosis; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003363:Cost Control; D006046:Gold / Q000009:adverse effects / Q000627:therapeutic use*; D006417:Hematuria / Q000139:chemically induced / Q000175:diagnosis; D006801:Humans; D008991:Monitoring, Physiologic; D011507:Proteinuria / Q000139:chemically induced / Q000175:diagnosis; D013921:Thrombocytopenia / Q000139:chemically induced / Q000175:diagnosis
D006046:Gold